Nitrosamines, such as N-nitrosodimethylamine (NDMA), are probable human carcinogens that pose significant health risks, including the potential for liver, stomach, and esophageal cancers. Nitrosamine Drug Substance Related Impurities (NDSRIs) resulting from API nitrosation are also of concern due to their potential genotoxicity. With regulatory agencies like the US FDA and The European Medicines Agency (EMA) setting stringent limits on acceptable nitrosamine levels in pharmaceutical products, it is crucial to ensure your drug formulations meet safety standards and protect patient health.
At BioPharmaSpec, we offer specialized testing for nitrosamine impurities using advanced, high-sensitivity techniques like GC-MS, LC-MS/MS, and LC-HRMS. Our experienced team manages the entire testing process, ensuring accurate and reliable results—without the need for costly investments in equipment or additional resources.
How Do Nitrosamines Form In My Product?
The formation of nitrosamines can occur through multiple pathways during the drug development and manufacturing processes. Identifying these sources is essential for effective control:
- Contamination: Nitrosamines can form during manufacturing when nitrite impurities react with amine precursors. Raw materials, including active pharmaceutical ingredients (APIs), may contain trace levels of nitrosamines.
- Degradation: Some drug substances or excipients may degrade over time to form nitrosamines.
- Excipients: Excipients or other ingredients in a drug formulation, like the primary packaging materials, may react under certain conditions to produce nitrosamines.
Given these factors, early detection and thorough risk assessments are key to ensuring compliance and minimizing health risks.
Why Use Biopharmaspec For Nitrosamine Testing
- Reduce Capital Investment: By partnering with BioPharmaSpec, you gain access to state-of-the-art testing instruments like the Waters Absolute Triple Quad Mass Spectrometer (TQ-A), used in our laboratories for nitrosamine testing, alongside other LC-HRMS, LC-MS/MS and GC-MS instrumentation, allowing you to leverage our advanced capabilities without the capital cost of instrument investment.
- Highly Experienced Scientists: Our team combines decades of expertise in nitrosamine analysis, ensuring both precise instrument operation and expert data interpretation. This expertise guarantees accurate, reliable results every time.
- Tailored Testing to Meet Your Needs: Recognizing that each product and supply chain is unique, BioPharmaSpec provides customizable testing and analytical solutions to address specific needs. We offer targeted analyses for Nitrosamine Drug Substance Related Impurities (NDSRIs) and other forms of contamination, giving you confidence that your product meets the necessary regulatory benchmarks.
We Use Advanced Analytical Methods for Reliable Results
At BioPharmaSpec, we rely on cutting-edge analytical techniques to ensure our nitrosamine testing delivers precise, consistent and reproducible results. Our suite of instruments includes highly sensitive mass spectrometers that will detect nitrosamines at trace levels:
- GC-MS (Gas Chromatography-Mass Spectrometry): This technique is used for detecting volatile and semi-volatile nitrosamine compounds, offering exceptional sensitivity.
- LC-MS/MS (Liquid Chromatography-Mass Spectrometry): This technique is highly effective for quantifying both volatile and non-volatile nitrosamine impurities, ensuring reliable results even at low concentrations.
- LC-HRMS (High-Resolution Mass Spectrometry): Known for its superior resolution, LC-HRMS allows for precise identification and quantification of nitrosamines, particularly in complex matrices with trace impurities.
We cover a wide range of common nitrosamines, including:
- NDMA (N-nitrosodimethylamine)
- NDEA (N-nitrosodiethylamine)
- NDiPA (N-nitrosodiisopropylamine)
- NDBA (N-nitrosodibutylamine)
- NMBA (N-nitroso-N-methyl-4-aminobutyric acid)
- NEiPA (N-nitrosoethylisopropylamine)
- NDPA (N-nitrosodipropylamine)
- NMPA (N-nitrosomethylphenylamine)
With our state-of-the-art instruments, including the Waters Absolute Triple Quad Mass Spectrometer (TQ-A), we can detect nitrosamines at concentrations below regulatory limits.
Nitrosamine Testing Process
BioPharmaSpec’s streamlined approach includes:
- Method Development: If needed, we develop custom testing methods to detect specific nitrosamines in your product, tailoring our approach to your unique needs.
- Sensitive Testing: Using advanced technologies like LC-MS/MS, GC-MS, and LC-HRMS, we identify nitrosamines with exceptional sensitivity, even at ultra-low concentrations.
- Analysis & Reporting: We deliver clear, actionable reports with comprehensive findings and expert recommendations, helping you make informed decisions.
Minimize the Risks of Nitrosamine Contamination
Contact BioPharmaSpec today to learn how our customized nitrosamine testing solutions can support the development of your biopharmaceuticals.